Clinical Trial Update: Maintenance AVElumab After SECond Line Platinum-based Chemotherapy for Metastatic Urothelial Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating maintenance therapy with avelumab after second-line platinum-based chemotherapy in metastatic urothelial carcinoma; the study status is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urothelial Carcinoma

Drugs mentioned

• BAVENCIO (AVELUMAB)

Snippet

Sponsor: Gruppo Oncologico Italiano di Ricerca Clinica | Conditions: Urothelial Carcinoma | Phase 2 | Status: NOT_YET_RECRUITING